Why an Exton pharma firm will benefit from Almirral's $550M deal with Allergan
September 21, 2018 at 11:22 AM EDT
The finalized deal between Almirall and Allergan involves four approved products and one under FDA review
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|